Evaluation of the specificity of [18F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [18F]FDG and impact of rituximab therapy
Crossref DOI link: https://doi.org/10.1186/s13550-015-0101-7
Published Online: 2015-04-14
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hovhannisyan, Narinée
Guillouet, Stéphane
Fillesoye, Fabien
Dhilly, Martine
Patin, Delphine
Galateau, Françoise
Leporrier, Michel
Barré, Louisa
License valid from 2015-04-14